TY - JOUR
T1 - Menopause depression
T2 - Under recognised and poorly treated
AU - Kulkarni, Jayashri
AU - Gurvich, Caroline
AU - Mu, Eveline
AU - Molloy, Grace
AU - Lovell, Sonya
AU - Mansberg, Ginni
AU - Horton, Shelly
AU - Morton, Erin
AU - Uppal, Talat
AU - Cashell, Ceri
AU - de Castella, Anthony
AU - Reisel, Dan
AU - Dear, Linda
AU - Weatherburn-Reeves, Naomi
AU - Harris, Katie
AU - Pietrobon, Kerry
AU - Teagle, Kelly
AU - Kim, Bo Youn
AU - Newson, Louise
AU - Szoeke, Cassandra
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/8
Y1 - 2024/8
N2 - Menopause is a biological process experienced by all people assigned female at birth. A significant number of women experience mental ill health related to the major brain gonadal hormone shifts that occur in their midlife. There is poor understanding and management of the complex mental ill health issues, with the biological brain hormone changes receiving little formal attention. The current treatment advice is to manage this special type of mental ill health in the same way that all mental ill health is managed. This leads to poor outcomes for women and their families. Many women leave the workforce earlier than expected due to menopause-related depression and anxiety, with subsequent loss of salary and superannuation. Others describe being unable to adequately parent or maintain meaningful relationships – all ending in a poor quality of life. We are a large and diverse group of national and international clinicians, lived experience and social community advocates, all working together to innovate the current approaches available for women with menopausal mental ill health. Above all, true innovation is only possible when the woman with lived experience of menopause is front and centre of this debate.
AB - Menopause is a biological process experienced by all people assigned female at birth. A significant number of women experience mental ill health related to the major brain gonadal hormone shifts that occur in their midlife. There is poor understanding and management of the complex mental ill health issues, with the biological brain hormone changes receiving little formal attention. The current treatment advice is to manage this special type of mental ill health in the same way that all mental ill health is managed. This leads to poor outcomes for women and their families. Many women leave the workforce earlier than expected due to menopause-related depression and anxiety, with subsequent loss of salary and superannuation. Others describe being unable to adequately parent or maintain meaningful relationships – all ending in a poor quality of life. We are a large and diverse group of national and international clinicians, lived experience and social community advocates, all working together to innovate the current approaches available for women with menopausal mental ill health. Above all, true innovation is only possible when the woman with lived experience of menopause is front and centre of this debate.
KW - gonadal hormones
KW - Menopause
KW - menopause hormone therapy
UR - http://www.scopus.com/inward/record.url?scp=85193731123&partnerID=8YFLogxK
U2 - 10.1177/00048674241253944
DO - 10.1177/00048674241253944
M3 - Article
C2 - 38761367
AN - SCOPUS:85193731123
SN - 0004-8674
VL - 58
SP - 636
EP - 640
JO - Australian and New Zealand Journal of Psychiatry
JF - Australian and New Zealand Journal of Psychiatry
IS - 8
ER -